Results 91 to 100 of about 6,608 (209)
Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review
ABSTRACT Inherited metabolic diseases (IMDs) are genetic disorders that disrupt biochemical processes in the human body, due to pathogenic variants in genes encoding enzymes or transporters. While IMDs are mostly diagnosed in infancy or childhood, there is an increasing number of diagnoses in adult patients.
Maria‐Rita Moio +7 more
wiley +1 more source
High Prevalence of GALC Gene Variants in Adults With Neurodegenerative Conditions
GALC Defects and Neurodegenerative Impact: Exploring the role of GALC variants in adults with neurodegenerative symptoms and identifying an undiagnosed case of adult‐onset Krabbe disease. Metabolic Interplay: Focus on interrelated pathways as potential risk factors for neurodegeneration in heterozygous lysosomal storage disorder carriers.
Federica Feo +17 more
wiley +1 more source
MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock [PDF]
Background: MAPK-activated protein kinase 2 (MK2) plays a pivotal role in the cell response to (inflammatory) stress. Among others, MK2 is known to be involved in the regulation of cytokine mRNA metabolism and regulation of actin cytoskeleton dynamics ...
Vandendriessche, Benjamin +5 more
core +1 more source
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis
ABSTRACT GM1 and GM2 gangliosidosis are inherited, progressive, neurodegenerative lysosomal disorders of variable onset and disease progression. GM1 gangliosidosis is a result of biallelic pathogenic variants in the GLB1 gene, which confer absent or reduced β‐galactosidase enzyme activity and lead to the accumulation of glycoconjugates such as ...
Sydney Stern +4 more
wiley +1 more source
Organelle‐Targeting Nanoparticles
This review examines nanoparticle‐based therapies targeting organelles like the nucleus, mitochondria, and lysosomes. Nanoparticle design, targeting strategies, and their applications in treating diseases linked to organelle dysfunction are discussed, highlighting the potential for improved treatment outcomes and reduced off‐target effects.
John Soukar +2 more
wiley +1 more source
A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia
Lysosomal storage diseases (LSDs) are a group of about 50 inborn errors of metabolism characterized by the lysosomal accumulation of partially or non-degraded molecules due to mutations in proteins involved in the degradation of macromolecules, transport,
María Alejandra Puentes-Tellez +9 more
doaj +1 more source
Fingolimod for the treatment of neurological diseases—state of play and future perspectives [PDF]
Sphingolipids are a fascinating class of signaling molecules derived from the membrane lipid sphingomyelin. They show abundant expression in the brain.
Rajkumar Vutukuri +2 more
core +2 more sources
Sandhoff disease (SD) is a glycosphingolipid storage disease that arises from mutations in the Hexb gene and the resultant deficiency in β-hexosaminidase activity.
Yasuhiro Ogawa +8 more
doaj +1 more source
A Fatal Case of Generalized Lysosomal Storage Disease in an Infant. [PDF]
Gangliosidoses are a heterogeneous group of lysosomal storage diseases with an autosomal recessive trait, which are characterized by the intracellular accumulation of gangliosides in several tissues, mainly in neurons.
Ancer Rodríguez, Jesús +7 more
core
Background Neurological disorders are a common cause of morbidity and mortality within Pakistani populations. It is one of the most important challenges in healthcare, with significant life-long socio-economic burden. Methods We investigated the cause of
Shazia Khan +10 more
doaj +1 more source

